Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-29

Clinical Trial Update: Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3, placebo-controlled trial evaluating cetirizine for perennial allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine (cetirizine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED